Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SAKK 08/15 - PROMET - Multicenter, Randomized Phase II Trial of Salvage Radiotherapy +/- Metformin for Patients With Prostate Cancer After Prostatectomy

NCT02945813 is registered in ClinicalTrials.gov with Swiss Cancer Institute as lead sponsor.

NCT NCT02945813
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02945813 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SAKK 08/15 - PROMET - Multicenter, Randomized Phase II Trial of Salvage Radiotherapy +/- Metformin for Patients With Prostate Cancer After Prostatectomy
Lead sponsor
Swiss Cancer Institute
Phase
Phase 2
Overall status
Terminated
Start date
October 24, 2017
Completion date
February 28, 2022
Enrollment
112 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer